Understanding the molecular makeup of low grade glioma and DIPG
Molecular pathophysiology of histone G34R mutated childhood brain tumours: towards the development of novel targeted therapies
We have been funding expert research since 2016, aiming to ensure that every child and young person has a safe and effective treatment for their cancer, and that they can live long and happy lives post-treatment.
Molecular pathophysiology of histone G34R mutated childhood brain tumours: towards the development of novel targeted therapies
Minimal residual disease detection of ependymoma by microRNA biomarker profile evaluation as part of SIOP Ependymoma II trial
Investigating the arginine auxotrophy of paediatric brain tumours
Improving the diagnosis of children’s brain tumours by Functional Radiomics
Comprehensive molecular characterization of paediatric spinal ependymomas
Molecular profiling of relapsing craniopharyngioma
In vitro evaluation of the potential of glucose restriction as an adjuvant therapy for paediatric brain tumours
Defining the cellular origins of neonatal and paediatric brain tumours
Identifying the metabolic ‘Achilles Heel’ of childhood brain cancers